Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repetitive Intramyocardial CD34+ Cell Therapy in Dilated Cardiomyopathy

NCT02248532 is registered in ClinicalTrials.gov with University Medical Centre Ljubljana as lead sponsor.

NCT NCT02248532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02248532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repetitive Intramyocardial CD34+ Cell Therapy in Dilated Cardiomyopathy
Lead sponsor
University Medical Centre Ljubljana
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2014
Completion date
December 31, 2017
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dilated cardiomyopathy, heart failure